OmicsChart

AI in biopharma only delivers value when data, analysis, and decisions are tightly connected

OmicsChart was founded in 2023, is headquartered in Martinsried, Germany, lists 1–10 employees, and has $20K in recorded funding across 1 round.

Headquarters
Martinsried
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$20K
Last Round
$20K SeedJun 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

OmicsChart (now rebranded as Vedaly) is a patient-centric cancer data and analytics platform for translational cancer biologists and biopharma R&D teams. The platform enables translational and R&D teams to architect scalable data foundations, integrate complex biological and clinical data, and operationalize AI so it directly informs scientific and strategic decisions. OmicsChart joined the Milner Therapeutics Institute network at Cambridge University in 2024 and rebranded to Vedaly in November 2025 to reflect its expanded scope of services.

Summary

OmicsChart is an Artificial Intelligence company based in Martinsried, Germany, founded in 2023. It lists 1–10 employees. It has raised $20K in total across 1 round, most recently a $20K Seed round in Jun 2023. Investors include Techstars, PharmStars and Debiopharm Innovation.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJun 2023
$20K

Investors

Similar Companies

Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
PalantirIPO

Palantir Technologies builds data integration and analytics platforms (Gotham and Foundry) for go...

Denver, United States1001–5000Analytics, Artificial Intelligence
Private EquityTotal funding$3.1BJul 2020
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Cyera

Cyera provides an AI-powered data security platform that helps security teams discover, control, ...

New York, United States201–500Artificial Intelligence, Cybersecurity
Extension RoundTotal funding$2.8BSep 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OmicsChart on Indexed.vc
<a href="https://indexed.vc/companies/omicschart"><img src="https://indexed.vc/api/badge/company/omicschart" alt="OmicsChart on Indexed.vc" width="260" height="76" /></a>